scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1471-4159.1982.TB07996.X |
P698 | PubMed publication ID | 7142992 |
P50 | author | Bengt Winblad | Q66000726 |
P2093 | author name string | Finch CE | |
Marcusson J | |||
Severson JA | |||
P2860 | cites work | Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions | Q35355783 |
Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sites | Q35368949 | ||
Multiple receptors for dopamine | Q37876912 | ||
Aging and Extrapyramidal Function | Q39129889 | ||
Striatal lesions with kainic acid: neurochemical characteristics | Q39147642 | ||
Long-term sequelae of striatal kainate lesion | Q39207491 | ||
Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra | Q39251718 | ||
Neurotransmitter Receptors in Frontal Cortex of Schizophrenics | Q39261348 | ||
Bilateral projections from precentral motor cortex to the putamen and other parts of the basal ganglia. An autoradiographic study in Macaca fascicularis | Q39336189 | ||
Neurotransmitter receptor alterations in Parkinson's disease | Q40093350 | ||
Cyclic AMP and cyclic GMP accumulation in vitro in brain regions of young, old and aged rats | Q40122596 | ||
Cells of origin and terminal distrubution of corticostriatal fibers arising in the sensory-motor cortex of monkeys | Q41238210 | ||
Elevation of brain neuroleptic/dopamine receptors in schizophrenia | Q41530785 | ||
Aging process affects a single class of dopamine receptors | Q41647482 | ||
3H-Spiperone binding in normal and schizophrenic post-mortem human brain | Q41970620 | ||
Reduced dopaminergic binding during aging in the rodent striatum | Q42242712 | ||
Evidence for selective loss of brain dopamine- and histamine-stimulated adenylate cyclase activities in rabbits with aging | Q42472801 | ||
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations | Q45302799 | ||
Age-related Changes in the Nigrostriatum: A Behavioral and Biochemical Analysis | Q48165086 | ||
Dopamine receptor binding of 3H-ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) regulated by guanyl nucleotides | Q48167713 | ||
An anatomy of schizophrenia? | Q48642309 | ||
Age-related alterations in the rodent brain cholinergic system and behavior | Q52105726 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dopamine | Q170304 |
P304 | page(s) | 1623-1631 | |
P577 | publication date | 1982-12-01 | |
P1433 | published in | Journal of Neurochemistry | Q6295643 |
P1476 | title | Age-correlated loss of dopaminergic binding sites in human basal ganglia | |
P478 | volume | 39 |
Q44515489 | A post-mortem study on striatal dopamine receptors in Parkinson's disease |
Q37889478 | ARAC--The Montreal Jewish General Hospital Alzheimer Risk Assessment Clinic |
Q37735812 | Age and Parkinson's disease-related neuronal death in the substantia nigra pars compacta. |
Q36533947 | Age and sex related differences in subcortical brain iron concentrations among healthy adults |
Q33590439 | Age influences magnitude but not duration of response to levodopa |
Q42447259 | Age-correlated changes in dopaminergic nigrostriatal perikarya of the C57BL/6NNia mouse |
Q48131180 | Age-related Changes in the Nigrostriatal System |
Q36730787 | Age-related changes in binding of the D2/3 receptor radioligand [(11)C](+)PHNO in healthy volunteers |
Q67898218 | Age-related changes in human D1 dopamine receptors measured by positron emission tomography |
Q30418974 | Age-related changes in signal transduction. Implications for neuronal transmission and potential for drug intervention |
Q71345014 | Age-related decrease in responsiveness to L-DOPA is not due to changes in dopamine receptor mRNAs or G protein mRNAs |
Q34627373 | Ageing and the nigrostriatal dopaminergic system |
Q48222022 | Aging of the nigrostriatal pathway in humans |
Q35732274 | Alzheimer's disease - not an exaggeration of healthy aging |
Q44282697 | Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics |
Q42518494 | Basal Ganglia Dopamine Receptor Autoradiography and Age-related Movement Disorders |
Q36929398 | Behavioral and metabolic characterization of heterozygous and homozygous POLG mutator mice |
Q34510415 | Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease |
Q35223065 | Correlations of striatal dopamine synthesis with default network deactivations during working memory in younger adults |
Q44237558 | D1and D2Dopamine Receptors in Human Substantia Nigra: Localization and the Effect of Aging |
Q42208997 | Dihydroergocryptine improves behavioral deficits of aged male rats |
Q46190328 | Disappearance of GAD-mRNA and tyrosine hydroxylase in substantia nigra following striatal ibotenic acid lesions: Evidence for transneuronal regression |
Q45291180 | Dopamine D2 receptor SPECT imaging: basic in vivo characteristics and clinical applications of 123I-IBZM in humans |
Q35631615 | Dopamine and frontostriatal networks in cognitive aging |
Q39761733 | Dopamine and serotonin systems in human and rodent brain: effects of age and neurodegenerative disease |
Q46322618 | Dopaminergic Changes in the Basal Ganglia A Generalized Phenomenon of Aging in Mammals |
Q48229063 | Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine |
Q36779439 | Drugs of abuse and the aging brain |
Q34256020 | Effects of Age on Dopamine and Serotonin Receptors Measured by Positron Tomography in the Living Human Brain |
Q41664306 | Effects of PPP1R1B (DARPP-32) Polymorphism on Feedback-Related Brain Potentials Across the Life Span |
Q48680469 | Effects of clozapine and haloperidol on baseline levels of vacuous jaw movements in aged rats. |
Q48541504 | Effects of morphine and aging on brain calmodulin levels in mice |
Q86630273 | Functional and neurobiological similarities of aging in monkeys and humans |
Q35612951 | Human serum Cohn fraction IV (alpha-globulin [correction of globin] enriched) inhibits ligand binding at neurotransmitter receptors in human brain |
Q37404614 | Human striatal dopamine receptors are organized in compartments |
Q41151744 | In vitro assessment of neurotrophic activity from the striatum of aging rats |
Q33620597 | In vivo imaging of cerebral dopamine D3 receptors in alcoholism. |
Q36254347 | Lack of age-dependent decrease in dopamine D3 receptor availability: a [(11)C]-(+)-PHNO and [(11)C]-raclopride positron emission tomography study |
Q48361745 | Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy |
Q39639357 | Neurodegenerative disorders and aging. Alzheimer's disease and Parkinson's disease--common ground |
Q28201402 | Neuron-specific age-related decreases in dopamine receptor subtype mRNAs |
Q43081301 | Neuroprotective effects of herbal ethanol extracts from Gynostemma pentaphyllum in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. |
Q70180703 | Neurotransmitter Receptors and Aging |
Q40079033 | Neurotransmitter receptors in the central nervous system and aging: Pharmacological aspect (review) |
Q42471439 | Ontogeny of the electrophysiological activity of dopaminergic cells with special reference to the influence of adrenal medullary grafts on aging |
Q69833378 | Opiate receptor characteristics in brains from young, mature and aged mice |
Q45765813 | Pitfalls in membrane binding sites studies in post-mortem human brain |
Q26865145 | Primate aging in the mammalian scheme: the puzzle of extreme variation in brain aging |
Q42144670 | Prolonged P300 latency in children with the D2 dopamine receptor A1 allele. |
Q48417560 | Quantitative imaging of neuroreceptors in the living human brain |
Q47620139 | Recollection-related increases in functional connectivity across the healthy adult lifespan |
Q39485807 | Regionally selective manifestations of neostriatal aging |
Q33894630 | Relationship of striatal dopamine synthesis capacity to age and cognition |
Q33627591 | Striatal dopamine D2 receptors in tardive dyskinesia: PET study |
Q41278279 | Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels |
Q39472243 | The ageing brain, neuroleptic drugs and the enigma of schizophrenia |
Q35211789 | The ageing brain: normal and abnormal memory |
Q39608202 | The neural basis of memory decline in aged monkeys |
Search more.